US4152170A
(en)
*
|
1975-06-18 |
1979-05-01 |
Sumitomo Chemical Company, Ltd. |
Cross-linked pullulan
|
US4344930A
(en)
*
|
1975-10-30 |
1982-08-17 |
Colgate-Palmolive Company |
Skin care sponge
|
US4470975A
(en)
*
|
1977-10-21 |
1984-09-11 |
The Johns Hopkins University |
Method and composition for the elimination of water from an animal body
|
SE445013B
(sv)
*
|
1979-06-21 |
1986-05-26 |
Landstingens Inkopscentral |
Medel for att forebygga eller behandla infektioner hos menniskor och djur
|
US4292972A
(en)
*
|
1980-07-09 |
1981-10-06 |
E. R. Squibb & Sons, Inc. |
Lyophilized hydrocolloio foam
|
EP0086627B1
(fr)
*
|
1982-02-12 |
1985-08-28 |
Unitika Ltd. |
Produit anti-cancéreux
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US4783448A
(en)
*
|
1983-06-07 |
1988-11-08 |
Perstorp Ab |
Method for cleansing an infected sore
|
SE456346B
(sv)
*
|
1984-07-23 |
1988-09-26 |
Pharmacia Ab |
Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
|
US4769022A
(en)
*
|
1986-05-02 |
1988-09-06 |
Minnesota Mining And Manufacturing Company |
Cleansing pad
|
SE452469B
(sv)
*
|
1986-06-18 |
1987-11-30 |
Pharmacia Ab |
Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
|
US4851232A
(en)
*
|
1987-02-13 |
1989-07-25 |
Alza Corporation |
Drug delivery system with means for obtaining desirable in vivo release rate pattern
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5354290A
(en)
*
|
1989-05-31 |
1994-10-11 |
Kimberly-Clark Corporation |
Porous structure of an absorbent polymer
|
CA2017570C
(fr)
*
|
1989-05-31 |
2000-12-19 |
James R. Gross |
Structure poreuse d'un polymere absorbant
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5241009A
(en)
*
|
1990-05-07 |
1993-08-31 |
Kimberly-Clark Corporation |
Polymeric composition containing carboxy nueutralized with lithium or potassium
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
WO1993004732A1
(fr)
|
1991-09-09 |
1993-03-18 |
The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Procedes et dispositifs pour traiter l'hemophilie et le sida
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
US5502082A
(en)
*
|
1991-12-20 |
1996-03-26 |
Alliedsignal Inc. |
Low density materials having good compression strength and articles formed therefrom
|
US5525710A
(en)
*
|
1991-12-20 |
1996-06-11 |
Alliedsignal Inc. |
Highly porous chitosan bodies
|
ES2118219T3
(es)
*
|
1991-12-20 |
1998-09-16 |
Allied Signal Inc |
Materiales de baja densidad que tienen alta superficie especifica, y articulos formados a partir de ellos para uso en la recuperacion de metales.
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
DE4209160A1
(de)
*
|
1992-03-20 |
1993-09-30 |
Bauer Kurt Heinz Prof Dr |
Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5409703A
(en)
*
|
1993-06-24 |
1995-04-25 |
Carrington Laboratories, Inc. |
Dried hydrogel from hydrophilic-hygroscopic polymer
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
US5840338A
(en)
*
|
1994-07-18 |
1998-11-24 |
Roos; Eric J. |
Loading of biologically active solutes into polymer gels
|
DE4442605A1
(de)
*
|
1994-11-30 |
1996-06-05 |
Degussa |
Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
|
DE4442606C2
(de)
*
|
1994-11-30 |
1998-09-17 |
Degussa |
Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
DE19729273C2
(de)
*
|
1997-07-09 |
2000-08-17 |
Aventis Res & Tech Gmbh & Co |
Thermoplastische Mischung auf 1,4-alpha-D-Polyglucanbasis, Verfahren zu deren Herstellung und Verwendung
|
DK1017392T3
(da)
|
1997-09-25 |
2002-10-21 |
Bayer Ag |
Lægemiddel
|
US6261679B1
(en)
*
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
EP1104324B8
(fr)
*
|
1998-08-14 |
2011-06-22 |
Incept Llc |
Appareil servant a former des hydrogels in situ
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
US6703047B2
(en)
*
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
US6152943A
(en)
*
|
1998-08-14 |
2000-11-28 |
Incept Llc |
Methods and apparatus for intraluminal deposition of hydrogels
|
US7790192B2
(en)
|
1998-08-14 |
2010-09-07 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US6605294B2
(en)
|
1998-08-14 |
2003-08-12 |
Incept Llc |
Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
|
ES2241314T3
(es)
*
|
1998-08-31 |
2005-10-16 |
Cornell Research Foundation, Inc. |
Monoesteres de acido maleico-dextrano e hidroogeles basados en ellos.
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
WO2000025753A2
(fr)
*
|
1998-11-02 |
2000-05-11 |
Alza Corporation |
Administration regulee d'agents actifs
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
US6060461A
(en)
*
|
1999-02-08 |
2000-05-09 |
Drake; James Franklin |
Topically applied clotting material
|
US6716445B2
(en)
*
|
1999-04-12 |
2004-04-06 |
Cornell Research Foundation, Inc. |
Hydrogel entrapping therapeutic agent and stent with coating comprising this
|
CA2368617C
(fr)
*
|
1999-04-12 |
2010-03-16 |
Cornell Research Foundation, Inc. |
Systeme de formation d'hydrogel a composants hydrophobes et hydrophiles
|
US6541678B2
(en)
*
|
1999-09-27 |
2003-04-01 |
Brennen Medical, Inc. |
Immunostimulating coating for surgical devices
|
EP1239840B1
(fr)
*
|
1999-12-09 |
2005-04-06 |
Alza Corporation |
Medication antivirale
|
WO2002045695A2
(fr)
|
2000-12-05 |
2002-06-13 |
Alexander Macgregor |
Systeme de distribution hydrostatique regulee d'un agent
|
US20040219186A1
(en)
*
|
2001-08-16 |
2004-11-04 |
Ayres James W. |
Expandable gastric retention device
|
AU2002357935A1
(en)
*
|
2001-12-18 |
2003-06-30 |
Alza Corporation |
Dosage form for providing time-varying patterns of drug delivery
|
CN1606432A
(zh)
*
|
2001-12-19 |
2005-04-13 |
阿尔扎公司 |
用于增加亲水性大分子的口服生物利用度的制剂和剂型
|
HUP0402661A3
(en)
*
|
2001-12-19 |
2008-04-28 |
Alza Corp |
Formulation and dosage form for the controlled delivery of therapeutic agents
|
AU2003234216A1
(en)
*
|
2002-04-29 |
2003-11-17 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
AU2003245345A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
US7776314B2
(en)
*
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
AU2003256848A1
(en)
*
|
2002-07-29 |
2004-02-16 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
GB2395126A
(en)
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
NZ540352A
(en)
|
2002-11-26 |
2008-01-31 |
Genencor Int |
Method for preparing a solid material containing a hydrophilic polymer and immobilised proteorhodopsin (PR) thereby making a fraud-proof ink
|
US8709038B2
(en)
*
|
2002-12-20 |
2014-04-29 |
Boston Scientific Scimed, Inc. |
Puncture hole sealing device
|
US20040122349A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Lafontaine Daniel M. |
Closure device with textured surface
|
WO2004064772A2
(fr)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methodes et formes posologiques comprenant des couches a viscosite modifiee
|
DE10318802A1
(de)
*
|
2003-04-17 |
2004-11-04 |
Aesculap Ag & Co. Kg |
Selbsthaftendes resorbierbares Hämostyptikum
|
US9289195B2
(en)
|
2003-06-04 |
2016-03-22 |
Access Closure, Inc. |
Auto-retraction apparatus and methods for sealing a vascular puncture
|
US7331979B2
(en)
*
|
2003-06-04 |
2008-02-19 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
EP1638529B1
(fr)
|
2003-06-16 |
2016-08-10 |
ANDRX Pharmaceuticals, LLC. |
Composition orale a liberation prolongee
|
US7942897B2
(en)
*
|
2003-07-10 |
2011-05-17 |
Boston Scientific Scimed, Inc. |
System for closing an opening in a body cavity
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
PL1842533T3
(pl)
*
|
2003-08-06 |
2013-08-30 |
Gruenenthal Gmbh |
Postać aplikacyjna zabezpieczona przed nadużyciem
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
AU2004268549A1
(en)
*
|
2003-08-22 |
2005-03-10 |
Alza Corporation |
Stepwise delivery of topiramate over prolonged period of time
|
WO2005020959A2
(fr)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Compositions medicamenteuses et formes pharmaceutiques de topiramate
|
US20050158382A1
(en)
*
|
2003-09-26 |
2005-07-21 |
Evangeline Cruz |
Controlled release formulations of opioid and nonopioid analgesics
|
US20050089570A1
(en)
*
|
2003-09-26 |
2005-04-28 |
Evangeline Cruz |
Oros push-stick for controlled delivery of active agents
|
ATE544447T1
(de)
*
|
2003-09-26 |
2012-02-15 |
Alza Corp |
Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
|
CN1905857A
(zh)
*
|
2003-11-14 |
2007-01-31 |
阿尔扎公司 |
液体剂型的托吡酯的受控释放
|
US20050107867A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Taheri Syde A. |
Temporary absorbable venous occlusive stent and superficial vein treatment method
|
CN1905856A
(zh)
*
|
2003-12-23 |
2007-01-31 |
阿尔扎公司 |
用于增加受控递送的药物组合物的溶解度的方法和剂型
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
JP2007517063A
(ja)
*
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
トピラメートの新規な薬剤組成物および剤形
|
EP1701706A2
(fr)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Compositions medicamenteuses et formes pharmaceutiques
|
US20050234336A1
(en)
*
|
2004-03-26 |
2005-10-20 |
Beckman Andrew T |
Apparatus and method for marking tissue
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
WO2006007354A2
(fr)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Systeme d'administration par voie orale comprenant un complexe medicament/polymere
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US8080705B2
(en)
*
|
2004-07-28 |
2011-12-20 |
The Procter & Gamble Company |
Superabsorbent polymers comprising direct covalent bonds between polymer chain segments and method of making them
|
WO2006023286A2
(fr)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Formes posologiques renfermant une formulation d'agent actif nanoparticulaire a liberation retardee et procedes
|
US8348971B2
(en)
|
2004-08-27 |
2013-01-08 |
Accessclosure, Inc. |
Apparatus and methods for facilitating hemostasis within a vascular puncture
|
WO2006026412A2
(fr)
*
|
2004-08-31 |
2006-03-09 |
Vnus Medical Technologies, Inc. |
Dispositif et composition pour occlusion permanente d'une structure anatomique creuse
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US8262693B2
(en)
*
|
2004-11-05 |
2012-09-11 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
TW200635566A
(en)
*
|
2005-01-25 |
2006-10-16 |
Vnus Med Tech Inc |
Structures for permanent occlusion of a hollow anatomical structure
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
US20060257484A1
(en)
*
|
2005-04-19 |
2006-11-16 |
Hwang Stephen S |
Combination of tramadol and substances that comprise gabapentin
|
US7806856B2
(en)
*
|
2005-04-22 |
2010-10-05 |
Accessclosure, Inc. |
Apparatus and method for temporary hemostasis
|
JP5095615B2
(ja)
|
2005-06-27 |
2012-12-12 |
バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ |
ブプロピオン塩の放出調整製剤
|
JP2009500339A
(ja)
*
|
2005-06-29 |
2009-01-08 |
アルザ・コーポレーシヨン |
浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
|
JP2009507774A
(ja)
*
|
2005-08-04 |
2009-02-26 |
アルザ・コーポレーシヨン |
改良された性質を提供するポリマー混合物による半透過性膜を含んでなる浸透性用量形態物
|
US20070087061A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090041825A1
(en)
|
2006-02-10 |
2009-02-12 |
Kotov Nicholas A |
Cell culture well-plates having inverted colloidal crystal scaffolds
|
US8795709B2
(en)
*
|
2006-03-29 |
2014-08-05 |
Incept Llc |
Superabsorbent, freeze dried hydrogels for medical applications
|
US9017361B2
(en)
*
|
2006-04-20 |
2015-04-28 |
Covidien Lp |
Occlusive implant and methods for hollow anatomical structure
|
EP2077765A2
(fr)
*
|
2006-09-13 |
2009-07-15 |
Accessclosure, Inc. |
Appareil et procédés destinés à sceller une ponction vasculaire
|
US8623842B2
(en)
|
2006-09-27 |
2014-01-07 |
Hemostasis, Llc |
Hemostatic agent and method
|
US8414550B2
(en)
|
2006-09-29 |
2013-04-09 |
Lexion Medical, Llc |
System and method to vent gas from a body cavity
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
CN101485897B
(zh)
*
|
2008-01-14 |
2015-05-20 |
纪欣 |
生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
|
US20090062233A1
(en)
*
|
2007-08-09 |
2009-03-05 |
Xin Ji |
Modified starch material of biocompatible hemostasis
|
US7993367B2
(en)
*
|
2007-09-28 |
2011-08-09 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
US20090088723A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Accessclosure, Inc. |
Apparatus and methods for treating pseudoaneurysms
|
EP2209426A4
(fr)
*
|
2007-11-02 |
2015-04-22 |
Incept Llc |
Appareil et procédés de fermeture d'une perforation vasculaire
|
JP5774853B2
(ja)
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
US8642831B2
(en)
|
2008-02-29 |
2014-02-04 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
US8585646B2
(en)
|
2008-03-03 |
2013-11-19 |
Lexion Medical, Llc |
System and method to vent gas from a body cavity
|
US9061087B2
(en)
*
|
2008-03-04 |
2015-06-23 |
Hemostasis, Llc |
Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
|
US8029533B2
(en)
*
|
2008-04-04 |
2011-10-04 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9364206B2
(en)
|
2008-04-04 |
2016-06-14 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
EP2273983B1
(fr)
*
|
2008-05-09 |
2016-07-20 |
Grünenthal GmbH |
Procédé de préparation d'une formulation de poudre intermédiaire et d'une forme galénique solide finale en utilisant une étape de congélation par pulvérisation
|
US10799593B2
(en)
|
2008-06-09 |
2020-10-13 |
Northwestern University |
Nanodiamond particle complexes
|
US20100040672A1
(en)
*
|
2008-06-09 |
2010-02-18 |
Northwestern University |
Delivery of therapeutics
|
EP2364112B1
(fr)
|
2008-11-12 |
2016-03-09 |
Accessclosure, Inc. |
Appareil et procédés destinés à sceller une ponction vasculaire
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
AU2010246115A1
(en)
*
|
2009-05-04 |
2011-12-08 |
Incept. Llc |
Biomaterials for track and puncture closure
|
KR101772860B1
(ko)
|
2009-06-05 |
2017-08-30 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
T 세포 및 조혈 세포의 재프로그래밍
|
ES2560210T3
(es)
|
2009-07-22 |
2016-02-17 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación
|
JP5667183B2
(ja)
|
2009-07-22 |
2015-02-12 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
加熱溶融押出成型した制御放出性投与剤型
|
US20110052663A1
(en)
*
|
2009-09-01 |
2011-03-03 |
Hemostasis, Llc |
Hemostatic Sponge with Enzyme and Method of Manufacture
|
US8434489B2
(en)
|
2009-10-23 |
2013-05-07 |
Conceptus, Inc. |
Contraceptive devices and methods
|
IN2012DN05177A
(fr)
|
2009-12-15 |
2015-10-23 |
Incept Llc |
|
ES2606227T3
(es)
*
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
DE102010012183A1
(de)
*
|
2010-03-19 |
2011-09-22 |
Fresenius Medical Care Deutschland Gmbh |
Veresterte Polysaccharid-Osmotika
|
ES2665467T3
(es)
|
2010-03-29 |
2018-04-25 |
Astellas Pharma Inc. |
Composición farmacéutica de liberación modificada
|
KR20130137627A
(ko)
|
2010-09-02 |
2013-12-17 |
그뤼넨탈 게엠베하 |
음이온성 중합체를 포함하는 내변조성 투여형
|
RU2604676C2
(ru)
|
2010-09-02 |
2016-12-10 |
Грюненталь Гмбх |
Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
|
ES2870965T3
(es)
|
2011-01-19 |
2021-10-28 |
Access Closure Inc |
Procedimientos para sellar una punción vascular
|
US9820728B2
(en)
|
2011-01-19 |
2017-11-21 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9386968B2
(en)
|
2011-05-11 |
2016-07-12 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
WO2013017234A1
(fr)
|
2011-07-29 |
2013-02-07 |
Grünenthal GmbH |
Comprimé anti-manipulation permettant une libération immédiate de médicament
|
AR087359A1
(es)
|
2011-07-29 |
2014-03-19 |
Gruenenthal Gmbh |
Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
|
KR20190090048A
(ko)
|
2011-12-05 |
2019-07-31 |
인셉트, 엘엘씨 |
의료용 유기젤 방법 및 조성물
|
JP2012107033A
(ja)
*
|
2012-02-02 |
2012-06-07 |
Medafor Inc |
局所適用される凝血材料
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
WO2013131520A2
(fr)
|
2012-03-06 |
2013-09-12 |
Ferrosan Medical Devices A/S |
Récipient mis sous pression contenant de la pâte hémostatique
|
US8721680B2
(en)
|
2012-03-23 |
2014-05-13 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9757105B2
(en)
|
2012-03-23 |
2017-09-12 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
ES2692944T3
(es)
|
2012-04-18 |
2018-12-05 |
Grünenthal GmbH |
Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
RU2636240C2
(ru)
|
2012-06-12 |
2017-11-21 |
Ферросан Медикал Дивайсиз А/С |
Сухая гемостатическая композиция
|
AU2014273227B2
(en)
|
2013-05-29 |
2019-08-15 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
EP3003283A1
(fr)
|
2013-05-29 |
2016-04-13 |
Grünenthal GmbH |
Forme dosifiée inviolable à profil de libération bimodale
|
JP6390873B2
(ja)
|
2013-06-21 |
2018-09-19 |
フェッローサン メディカル ディバイス エー/エス |
減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
|
US10765774B2
(en)
|
2013-07-09 |
2020-09-08 |
Ethicon, Inc. |
Hemostatic pad assembly kit and method
|
EA032465B1
(ru)
|
2013-07-12 |
2019-05-31 |
Грюненталь Гмбх |
Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
|
WO2015078891A1
(fr)
|
2013-11-26 |
2015-06-04 |
Farmaceutici Formenti S.P.A. |
Préparation de composition pharmaceutique en poudre par cryo-broyage
|
RU2678592C1
(ru)
|
2013-12-11 |
2019-01-30 |
Ферросан Медикал Дивайсиз А/С |
Сухая композиция, содержащая компонент, улучшающий экструзию
|
CN106572980A
(zh)
|
2014-05-12 |
2017-04-19 |
格吕伦塔尔有限公司 |
包含他喷他多的防篡改即释胶囊制剂
|
EP3148512A1
(fr)
|
2014-05-26 |
2017-04-05 |
Grünenthal GmbH |
Microparticules protégées contre une libération massive dans l'éthanol
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
WO2016065245A1
(fr)
|
2014-10-24 |
2016-04-28 |
Incept, Llc |
Échafaudage extraluminal
|
JP7092502B2
(ja)
|
2014-12-10 |
2022-06-28 |
インセプト・リミテッド・ライアビリティ・カンパニー |
ハイドロゲル薬物送達インプラント
|
JP6747650B2
(ja)
|
2014-12-24 |
2020-08-26 |
フェロサン メディカル デバイシーズ エイ/エス |
第1の物質と第2の物質を保持し混合するためのシリンジ
|
KR20170139158A
(ko)
|
2015-04-24 |
2017-12-18 |
그뤼넨탈 게엠베하 |
즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
|
EP3294212B1
(fr)
|
2015-05-12 |
2023-10-25 |
Incept, LLC |
Administration de médicament à partir d'hydrogels
|
US10918796B2
(en)
|
2015-07-03 |
2021-02-16 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
CA2998259A1
(fr)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protection contre un surdosage par voie orale a l'aide de formulations a liberation immediate dissuasives d'abus
|
KR20180086468A
(ko)
|
2015-11-25 |
2018-07-31 |
인셉트, 엘엘씨 |
형상 변형 약물 전달 장치 및 방법
|
KR102520771B1
(ko)
|
2016-09-23 |
2023-04-12 |
인셉트, 엘엘씨 |
전안방내 약물 전달 데포
|
KR20200123181A
(ko)
|
2018-02-16 |
2020-10-28 |
에스페리온 테라피유틱스 인코포레이티드 |
뱀페도익산의 지속 방출형 제제
|
KR20210008479A
(ko)
|
2018-05-09 |
2021-01-22 |
훼로산 메디칼 디바이스 에이/에스 |
지혈 조성물을 제조하는 방법
|
CN110732037B
(zh)
|
2018-07-20 |
2023-05-26 |
广州倍绣生物技术有限公司 |
止血糊剂及其制备方法
|
JPWO2021029020A1
(fr)
|
2019-08-13 |
2021-02-18 |
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
CN113304305A
(zh)
*
|
2021-04-27 |
2021-08-27 |
宁波绿糖生物科技有限公司 |
一种葡聚糖微球及其制备方法和应用
|